Expression of Concern: Up‐regulation of Wnt‐1 and <i>β</i>‐catenin production in patients with advanced metastatic prostate carcinoma

Abstract

High levels of Wnt-1 and beta-catenin expression were associated with advanced, metastatic, hormone-refractory prostate carcinoma, in which they can serve as markers of disease progression.